Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-02-03 @ 10:07 AM
Study NCT ID:
NCT04811560
Status:
RECRUITING
Last Update Posted:
2025-12-10
First Post:
2021-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Sponsor:
Organization: